Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 98.99M | $ 20.62M | $ -2.5M | $ 0 | -18.3% |
3/31/2025 | $ 8.96M | $ 25.79M | $ -2.5M | $ 0 | -259.86% |
12/31/2024 | $ 11.63M | $ 39.21M | $ -2.5M | $ 0 | -315.67% |
9/30/2024 | $ 22.25M | $ 34.7M | $ -180K | $ 0 | -155.16% |
6/30/2024 | $ 39.11M | $ 34.24M | $ -180K | $ 0 | -87.08% |
3/31/2024 | $ 86.51M | $ 29.18M | $ -180K | $ 0 | -33.52% |
12/31/2023 | $ 85.92M | $ 26.73M | $ -180K | $ 0 | -30.9% |
9/30/2023 | $ 123.53M | $ 24.48M | $ 0 | $ 0 | -19.81% |
6/30/2023 | $ 126.73M | $ 24.52M | $ 30M | $ 0 | -43.02% |
3/31/2023 | $ 794.89M | $ 24.46M | $ 95.95M | $ 0 | -15.15% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for BIOXCEL THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 246.87M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.34B ]
(=) Shareholder Yield [ -18.4% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.38% |
max | 34.45% |
average | 0.59% |
median | 1.08% |
std | 11.11% |